News Image

What's going on in today's session

By Mill Chart

Last update: Oct 4, 2022

Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.

Today's top gainers

TickerChangeComment
EJH2.0K%E-HOME HOUSEHOLD SERVICE's (NASDAQ:EJH) stock price is advancing with 2.0K% to a price of $1.87. The stock is trading 50.58% lower than a month ago.
BTB192.0%BIT BROTHER LTD's (NASDAQ:BTB) stock price is advancing with 192.0% to a price of $0.33. Shareholders saw the stock price going 32.1% lower in the past month.
CNXA72.41%CONNEXA SPORTS TECHNOLOGIES's (NASDAQ:CNXA) shares rose 72.41% to $0.5 during Tuesday's session. The stock is trading 68.64% lower than a month ago.
SNTI64.81%SENTI BIOSCIENCES INC's (NASDAQ:SNTI) stock price is advancing with 64.81% to a price of $4.12. In the last month the share price increased with 26.9%.
AERC40.19%AEROCLEAN TECHNOLOGIES INC (NASDAQ:AERC) rose 40.19% to $4.5 during Tuesday's after hours session. The stock is trading 79.75% lower than 3 months ago.
INBX35.55%INHIBRX INC's (NASDAQ:INBX) shares rose 35.55% to $27.35. In the last month the share price increased with 24.88%.
ADVWW34.88%ADVANTAGE SOLUTIONS IN-CW25's (NASDAQ:ADVWW) stock price is advancing with 34.88% to a price of $0.15. The stock is trading 71.77% lower than a month ago.
VAPO30.3%VAPOTHERM INC's (NYSE:VAPO) shares rose 30.3% to $2.15. A press release (Vapotherm Announces Debt Amendment and NYSE Continued Listing Standard Notice) was released yesterday.
TUEM28.98%TUESDAY MORNING CORP's (NASDAQ:TUEM) shares rose 28.98% to $0.17. In the last month the share price dropped with 63.01%.
TDCX28.6%TDCX INC's (NYSE:TDCX) shares rose 28.6% to $11.91 during Tuesday's session. The stock is trading 61.69% lower than a year ago.

To see the full list of top gainers you can use our top gainers screener.

Losers

TickerChangeComment
ASZ.W-99.75%AUSTERLITZ ACQ CL A -CW27's (NYSE:ASZ.W) stock price decreased by 99.75% to $0.0. In the last 3 months the stock lost 38.65%.
KALV-54.69%KALVISTA PHARMACEUTICALS INC's (NASDAQ:KALV) stock price is declining with 54.69% to a price of $6.45. Earlier today the company had a press release: KalVista Pharmaceuticals Announces Termination of KVD824 Phase 2 KOMPLETE Trial for Prophylactic Treatment of Hereditary Angioedema.
FNHC-38.91%FEDNAT HOLDING CO's (NASDAQ:FNHC) shares fell 38.91% to $0.29. In the last month the share price increased with 56.67%.
OBLG-37.55%OBLONG INC's (NASDAQ:OBLG) shares fell 37.55% to $0.25. Shareholders saw the stock price going 54.14% higher in the past month.
FAZE-33.01%FAZE HOLDINGS INC's (NASDAQ:FAZE) stock price is declining with 33.01% to a price of $5.46. The stock is trading 53.24% lower than a month ago.
VSTM-31.25%VERASTEM INC's (NASDAQ:VSTM) shares fell 31.25% to $0.6. Earlier today the company had a press release: Verastem Oncology Announces RAMP VS-6766 Clinical Trials and Corporate Updates.
CRH.W-30.0%COHN ROBBINS HOLDINGS -CW25's (NYSE:CRH.W) shares fell 30.0% to $0.02. The stock is trading 96.76% lower than a month ago.
BOA.W-27.18%BOA ACQUISITION CL A -CW28's (NYSE:BOA.W) stock price decreased by 27.18% to $0.08. In the last month the stock gained 85.67%.
HLBZW-22.22%HELBIZ INC-CW24's (NASDAQ:HLBZW) shares fell 22.22% to $0.07 during Tuesday's session. In the last 6 months the share price dropped with 67.02%.
LTRYW-20.44%LOTTERY.COM -CW21's (NASDAQ:LTRYW) shares fell 20.44% to $0.02. Two days ago the company had a press release: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lottery.com, NIO, Bed Bath & Beyond, and Dingdong and Encourages Investors to Contact the Firm.

For the full top loser list go to our top losers screener.

Back

VERASTEM INC

NASDAQ:VSTM (4/22/2024, 7:00:03 PM)

After market: 9.74 0 (0%)

9.74

-0.1 (-1.02%)

VSTM News

News Image6 hours ago - Market News VideoVerastem is Now Oversold (VSTM)
News Image4 days ago - Verastem OncologyVerastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer
News Image14 days ago - GenFleet TherapeuticsGenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting

/PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today unveiled the...

News Image19 days ago - Verastem OncologyVerastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Imagea month ago - Verastem OncologyGlobal Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer
News Imagea month ago - InvestorPlaceVSTM Stock Earnings: Verastem Misses EPS for Q4 2023

VSTM stock results show that Verastem missed analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderVSTM Stock Earnings: Verastem Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Verastem (NASDAQ:VSTM) just reported results for the fourth quarter of 2023.Ver...

News Imagea month ago - Verastem OncologyVerastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates
News Imagea month ago - Verastem OncologyVerastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs
News Image2 months ago - Verastem OncologyVerastem Oncology Receives Orphan Drug Designation from FDA for Avutometinib Alone or in Combination With Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
News Image2 months ago - Verastem OncologyVerastem Oncology Announces Preclinical Presentations for New Oral G12D Inhibitor and for Avutometinib and Defactinib Combination as a Backbone of Therapy for RAS/MAPK Driven Cancers at AACR Annual Meeting 2024
News Image3 months ago - InvestorPlace3 Stocks That AI Predicts Will Deliver Triple-Digit Returns This Year: February 2024

Discover AI's top stock selections, meticulously analyzed for 2024, promising more than just returns but a revolution in your portfolio.

VSTM Links
Follow us for more